Breakthrough Drug Delivery System Targets Brain Cancer
Breakthrough Drug Delivery System Targets Brain Cancer
Updated at: June 9, 2026 at 01:45 AM
Treating malignant brain tumors like glioblastoma has long been a major medical challenge, primarily due to the blood-brain barrier (BBB).
Researchers are now using nanotechnology, such as specialized nanoparticles and liposomes, to improve drug stability and precision.
These systems are becoming increasingly versatile, capable of carrying not only chemotherapy but also gene-editing tools like CRISPR and immunotherapies.
By moving away from blunt, systemic treatments toward intelligent, stimuli-responsive delivery, medicine is getting closer to effectively reaching the heart of brain cancer.
